BioVascular, Inc. is a privately held biotechnology company.  Our major investors include Domain Associates, Merck KGaA and BB Biotech Ventures.  Prior to BioVascular's efforts, Merck KGaA discovered, developed and patented the leech-derived polypeptide, saratin.  This polypeptide was cloned into a yeast cell line for recombinant production.  Merck KGaA has exclusively licensed this technology to BioVascular.  BioVascular has developed this product to GMP standards and is evaluating the effects in clinical studies.



Jump to Merck

With a tradition of over three hundred years, Merck KGaA is the oldest pharmaceutical and chemical company in the world. Merck KGaA has 177 companies in 56 countries, which employ around 30,000 employees. The corporate headquarters are located in Darmstadt, Germany.



Jump to Domain Associates

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $1.4 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.

Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics.  The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 180 life-sciences companies.  The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.



Jump to BB Biotech Ventures

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Bellevue Asset Management Group, which has operations in Boston and Kusnacht/Zurich, Switzerland. BB BIOTECH VENTURES currently invests from Fund II, which has a size of USD 123 mn and was closed in 2005.


Website design: Evenayr Graphics, Portland Oregon,